Evidence map›Paper›PMID 32432716›Full record

ArticleJAMA psychiatry2020

Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder.

Meredith G Harris, Alan E Kazdin, Wai Tat Chiu, Nancy A Sampson, Sergio Aguilar-Gaxiola, Ali Al-Hamzawi, Jordi Alonso, Yasmin Altwaijri, Laura Helena Andrade, Graça Cardoso and 19 more

Open access · bronzeAbstract read
In one paragraph

Article in JAMA psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in psychiatry · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 18 countries.

Meredith G HarrisThe University of Queensland School of Public Health, Herston, Queensland, Australia.
Alan E KazdinDepartment of Psychology, Yale University, New Haven, Connecticut.
Wai Tat ChiuDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Nancy A SampsonDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Sergio Aguilar-GaxiolaCenter for Reducing Health Disparities, UC Davis Health System, Sacramento, California.
Ali Al-HamzawiAl-Qadisiya University College of Medicine, Diwaniya Governorate, Iraq.
Jordi AlonsoIMIM-Hospital del Mar Research Institute, Parc de Salut Mar, Barcelona, Spain.
Yasmin AltwaijriEpidemiology Section, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Laura Helena AndradeNúcleo de Epidemiologia Psiquiátrica (LIM 23), Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Graça CardosoLisbon Institute of Global Mental Health and Chronic Diseases Research Center, NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.
Alfredo CíaAnxiety Disorders Center, Buenos Aires, Argentina.
Silvia FlorescuNational School of Public Health, Management and Development, Bucharest, Romania.
Oye GurejeDepartment of Psychiatry, University College Hospital, Ibadan, Nigeria.
Chiyi HuShenzhen Institute of Mental Health, Shenzhen Kangning Hospital, Shenzhen, China.
Elie G KaramDepartment of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Lebanon.
Georges KaramDepartment of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Lebanon.
Zeina MneimnehSurvey Research Center, Institute for Social Research, University of Michigan, Ann Arbor.
Fernando Navarro-MateuUDIF-SM, Subdirección General de Planificación, Innovación y Cronicidad, Servicio Murciano de Salud, IMIB-Arrixaca, CIBERESP-Murcia, Murcia, Spain.
Bibilola D OladejiDepartment of Psychiatry, University College Hospital, Ibadan, Nigeria.
Siobhan O'NeillUlster University School of Psychology, Londonderry, United Kingdom.
Kate ScottDepartment of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand.
Tim SladeThe Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, New South Wales, Australia.
Yolanda TorresCenter for Excellence on Research in Mental Health, CES University, Medellín, Colombia.
Daniel VigoDepartment of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
Bogdan WojtyniakNational Institute of Public Health-National Institute of Hygiene, Warsaw, Poland.
Zahari ZarkovNational Center of Public Health and Analyses, Directorate of Mental Health and Prevention of Addictions, Sofia, Bulgaria.
Yuval ZivMental Health Services, Israeli Ministry of Health, Jerusalem, Israel.
Ronald C KesslerDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
WHO World Mental Health Survey Collaborators
Harvard University · USUniversity College Hospital, Ibadan · NGUniversity of Balamand · LBHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRIsrael Ministry of Health · ILKing Faisal Specialist Hospital & Research Centre · SANarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PLNational Center of Public Health and Analyses · BGNational School of Public Health, Management and Professional Development · ROServicio Murciano de Salud · ESShenzhen KangNing Hospital · CNThe University of Queensland · AUThe University of Sydney · AUUC Davis Health · USUniversidad CES · COUniversitat Pompeu Fabra · ESUniversity of Al-Qadisiyah · IQUniversity of Lisbon · PTUniversity of Michigan · USUniversity of Otago · NZ

Funding

Risk Factors for Psychopathology in the WHO WMH SurveysR01MH070884 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2005 to 2009
$6.0M
Social Role Disability and Mental-Physical Co-MorbidityR01MH069864 · NIMH · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI VON KORFF, MICHAEL R · 2004 to 2007
$2.2M
CROSS-NATIONAL STUDIES OF DRUG INVOLVEMENT: WMH2000R01DA016558 · NIDA · MICHIGAN STATE UNIVERSITY · PI ANTHONY, JAMES CHRISTOPHER · 2003 to 2008
$1.7M
World Mental Health Consortium Annual Meeting 2003-07R13MH066849 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HEERINGA, STEVEN G · 2003 to 2007
$735k
Lebanon-Epidemiology: The NCS Replication StudyR03TW006481 · FIC · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2004 to 2006
$142k
FIC NIH HHS R03 TW006481NIDA NIH HHS R01 DA016558NIMH NIH HHS R01 MH069864NIMH NIH HHS R01 MH070884NIMH NIH HHS R13 MH066849
6 · The paper itself

Abstract

Importance: The perceived helpfulness of treatment is an important patient-centered measure that is a joint function of whether treatment professionals are perceived as helpful and whether patients persist in help-seeking after previous unhelpful treatments. Objective: To examine the prevalence and factors associated with the 2 main components of perceived helpfulness of treatment in a representative sample of individuals with a lifetime history of DSM-IV major depressive disorder (MDD). Design, Setting, and Participants: This study examined the results of a coordinated series of community epidemiologic surveys of noninstitutionalized adults using the World Health Organization World Mental Health surveys. Seventeen surveys were conducted in 16 countries (8 surveys in high-income countries and 9 in low- and middle-income countries). The dates of data collection ranged from 2002 to 2003 (Lebanon) to 2016 to 2017 (Bulgaria). Participants included those with a lifetime history of treated MDD. Data analyses were conducted from April 2019 to January 2020. Data on socioeconomic characteristics, lifetime comorbid conditions (eg, anxiety and substance use disorders), treatment type, treatment timing, and country income level were collected. Main Outcomes and Measures: Conditional probabilities of helpful treatment after seeing between 1 and 5 professionals; persistence in help-seeking after between 1 and 4 unhelpful treatments; and ever obtaining helpful treatment regardless of number of professionals seen. Results: Survey response rates ranged from 50.4% (Poland) to 97.2% (Medellín, Columbia), with a pooled response rate of 68.3% (n = 117 616) across surveys. Mean (SE) age at first depression treatment was 34.8 (0.3) years, and 69.4% were female. Of 2726 people with a lifetime history of treatment of MDD, the cumulative probability (SE) of all respondents pooled across countries of helpful treatment after seeing up to 10 professionals was 93.9% (1.2%), but only 21.5% (3.2%) of patients persisted that long (ie, beyond 9 unhelpful treatments), resulting in 68.2% (1.1%) of patients ever receiving treatment that they perceived as helpful. The probability of perceiving treatment as helpful increased in association with 4 factors: older age at initiating treatment (adjusted odds ratio [AOR], 1.02; 95% CI, 1.01-1.03), higher educational level (low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), shorter delay in initiating treatment after first onset (AOR, 0.98; 95% CI, 0.97-0.99), and medication received from a mental health specialist (AOR, 2.91; 95% CI, 2.04-4.15). Decomposition analysis showed that the first 2 of these 4 factors were associated with only the conditional probability of an individual treatment professional being perceived as helpful (age at first depression treatment: AOR, 1.02; 95% CI, 1.01-1.02; educational level: low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high-average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), whereas the latter 2 factors were associated with only persistence (treatment delay: AOR, 0.98; 95% CI, 0.97-0.99; treatment type: AOR, 3.43; 95% CI, 2.51-4.70). Conclusions and Relevance: The probability that patients with MDD obtain treatment that they consider helpful might increase, perhaps markedly, if they persisted in help-seeking after unhelpful treatments with up to 9 prior professionals.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsEducational StatusFemaleGlobal HealthHealth SurveysHumansMajor Depressive DisorderMaleMiddle AgedPatient Acceptance of Health CarePatient CompliancePatient Satisfaction

Identifiers

PMID32432716
PMCPMC7240636
OpenAlexW3027050869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.